Gefitinib Tablets 250mg represent a specialized targeted therapy medication designed specifically for treating non-small cell lung cancer by inhibiting epidermal growth factor receptor tyrosine kinase activity. This sophisticated mechanism precisely blocks the cellular signals that drive cancer proliferation and survival, offering a more focused approach to cancer management. Each tablet contains 250mg of gefitinib as the active pharmaceutical ingredient, manufactured to ensure consistent dosage delivery and reliable therapeutic performance. The medication demonstrates particular effectiveness for patients whose cancer testing confirms specific EGFR mutations, providing a personalized treatment strategy that aligns with modern precision medicine principles. Healthcare professionals value these tablets for their ability to target cancer cells with accuracy while potentially minimizing impact on healthy cells.
This medication finds primary application within oncology departments across ...
Gefitinib Tablets 250mg represent a specialized targeted therapy medication designed specifically for treating non-small cell lung cancer by inhibiting epidermal growth factor receptor tyrosine kinase activity. This sophisticated mechanism precisely blocks the cellular signals that drive cancer proliferation and survival, offering a more focused approach to cancer management. Each tablet contains 250mg of gefitinib as the active pharmaceutical ingredient, manufactured to ensure consistent dosage delivery and reliable therapeutic performance. The medication demonstrates particular effectiveness for patients whose cancer testing confirms specific EGFR mutations, providing a personalized treatment strategy that aligns with modern precision medicine principles. Healthcare professionals value these tablets for their ability to target cancer cells with accuracy while potentially minimizing impact on healthy cells.
This medication finds primary application within oncology departments across various healthcare settings including comprehensive hospitals, specialized cancer treatment centers, and respiratory medicine clinics. It serves medical oncologists, pulmonologists, and respiratory specialists managing NSCLC cases with laboratory-confirmed EGFR mutations. The pharmaceutical supply chain encompassing distributors, wholesalers, and hospital procurement teams ensures this critical medication reaches healthcare providers worldwide. Oncology pharmacies and treatment facilities maintain adequate inventory to support both initial treatment cycles and ongoing maintenance therapy for eligible patients, establishing it as a fundamental component in contemporary cancer care protocols and treatment guidelines.
Business partners benefit from our dependable supply network that guarantees consistent availability of Gefitinib Tablets 250mg to meet market demands. We implement rigorous quality control measures throughout manufacturing and packaging processes, ensuring products comply with international pharmaceutical standards and regulatory requirements. The product's established efficacy in managing EGFR-positive NSCLC builds confidence among medical professionals and patients. We provide competitive pricing for volume orders while maintaining transparent business operations for pharmaceutical distributors and wholesalers, supporting their market operations with reliable product access and professional partnership.
Key Features:
- Contains 250mg gefitinib per tablet as the precise active ingredient
- Functions as EGFR tyrosine kinase inhibitor targeting specific cancer mechanisms
- Manufactured following strict quality protocols meeting international standards
- Available in commercial packaging configurations for distribution needs
- Supported by complete documentation including quality certificates
Benefits:
- Provides targeted therapy for EGFR mutation-positive NSCLC patients
- Offers precision treatment approach with potential reduced side effects
- Delivers consistent therapeutic performance through quality manufacturing
- Supports healthcare providers with reliable medication for cancer care
- Enables distributors to meet medical community needs with trusted product